Click on the image to see the full-sized ad and get all the info on AdPharm.

29 more Cymbalta ads on AdPharm, click here

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

I have poor leg circulation

And I have a good reason to try to reduce the risk of heart attack or stroke that comes with it.

Click on image to view ad details and full-size version on AdPharm.
To see all of this brand’s ads on AdPharm, click here

Click on image to view ad details and full-size version on AdPharm

To see all of this brand’s ads on AdPharm, click here

Click on thumbnail to view the full-size ad on AdPharm

Are you paying the price of fibromyalgia pain?
Cymbalta can help.

Brand name: Cymbalta
Generic name/category: Duloxetine, Serotonin-norepinephrine reuptake inhibitors (SNRI), Thiophenes
Company: Lilly
Country/Market: USA, North America
Indication(s)/use: Fibromyalgia
Target: Consumers (DTC)
Tagline: Fibromyalgia is painful. Cymbalta can help.
Medium: Print ad
Size/duration: single-page and One third of page
Publication/Aired: More – September 2009

To see all of this brand’s ads on AdPharm, click here

Living proof

ACS – PAD – Stroke – PAD – ACS
4 large trials involving more than 81,000 patients.

Plavix ??? the only prescription antiplatelet with proven efficacy and a well-established safety profile in a broad range of patients.

Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix, by Sun Pharmaceuticals under the trade name Clopilet, by Ranbaxy Laboratories under the trade name Ceruvin. It works by irreversibly inhibiting a receptor called P2Y12. Adverse effects include hemorrhage.

More on Wikipedia

Brand name: Plavix
Generic name/category: Clopidogrel, Antiplatelet drugs, ADP receptor inhibitors, Thiophenes, Prodrugs
Company: Sanofi-Aventis and Bristol-Myers Squibb
Country/Market: USA, North America
Indication(s)/use: inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease
Target: Healthcare Professionals (HCP)
Tagline: Living Proof.
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: The Journal of Invasive Cardiology – September 2009

To see all of this brand's ads on AdPharm, click here
0 views
Sep 11, 2009

Visit AdPharm.net for more pharmaceutical ads